Provider Notification: Change in Prior Authorization Requirements
Date: 08/01/19
Effective September 1, 2019, Buckeye Health Plan (Buckeye) is making changes to services requiring prior authorization for Medicaid members. This letter is provided as notification of the changes and also includes additional resource information related to the specific services that will be impacted.
Please note the following important changes:
- Infliximab-dyyb, Inflectra, Q5103
- Infliximab-abad, Renflexis, Q5104
- Infliximab, Remicade, J1745
On September 1, 2019, All Infliximab requests must be for infliximab-dyyb, Inflectra, Q5103 or infliximab-abad, Renflexis, Q5104. This includes continuation therapy unless contraindicated. This change effects the following site of care settings: provider-administered, outpatient hospital or ambulatory care center. To obtain more detailed information, please visit Buckeye’s website at www.buckeyehealthplan.com/providers or contact Provider Services at 866-296-8731.
To further assist you in this transition, you may access updated reference materials including Quick Reference Guides, copies of this notice and all enclosures on our website at www.buckeyehealthplan.com.
Please contact Buckeye’s Provider Services Department at 1-866-296-8731 with any questions. Thank you for your partnership and for the quality care you provider to Buckeye members.